7113

Top Glove Corporation Berhad

Sector: Healthcare | Market: MAIN

Key Financials

Extracted from official Bursa Malaysia quarterly filings. Latest 4 quarters, side by side.

Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025

Income Statement

Metric
Q2 FY2026
RM '000
Q1 FY2026
RM '000
Q4 FY2025
RM '000
Q3 FY2025
RM '000
Revenue1,005.025883.575889.621830.251
Operating expenses-971.182-842.932-856.241-821.932
Profit from operations33.84340.643--
Profit/(Loss) from operations--33.388.319
Other operating income11.06610.3333.26132.632
Share of results of an associate1.41.918-1.157-2.084
Profit/(Loss) before interest and tax--35.48438.867
Profit before interest and tax46.30952.894--
Interest income0.921.15621.5051.955
Finance costs-8.759-8.852-9.158-9.629
Profit/(Loss) before tax--47.83131.193
Profit before tax38.4745.198--
Income tax credit/(expense)---3.227
Income tax expense-7.261-6.373--
Income tax (expense)/credit---12.237-
Profit net of tax31.20938.825--
Profit/(Loss) net of tax--35.59434.42
Profit attributable to owners of the parent30.75938.583--
Profit/(Loss) attributable to Owners of the parent--38.56434.745
Basic EPS (sen)-00-
Profit attributable to Holders of Perpetual Sukuk0---
Profit/(Loss) attributable to Holders of Perpetual Sukuk--00
Profit/(Loss) attributable to: Non controlling interests---2.97-0.325
Profit attributable to Non controlling interests0.45---
Diluted EPS (sen)-00-
Profit attributable subtotal31.209---
Earnings/(Loss) per share attributable to owners of the parent, sen: Basic---0
Earnings/(Loss) per share attributable to owners of the parent, sen: Diluted---0
Basic earnings per share (sen)0---
Diluted earnings per share (sen)0---

Balance Sheet

Metric
Q2 FY2026
RM '000
Q1 FY2026
RM '000
Q4 FY2025
RM '000
Q3 FY2025
RM '000
ASSETS0.004000
Non current assets0000
Property, plant and equipment3,172.723,220.3593,295.913,386.227
Right-of-use assets164.903168.21165.036168.127
Investment properties485.492485.97474.31454.035
Investment in an associate and a joint venture7.0245.624--
Deferred tax assets19.66419.94821.22417.564
Biological assets0.3070.3280.3390.827
Investment in an associate--3.7064.863
Investment securities: Unquoted investments0.3920.3920.3920.392
Intangible assets855.933856.827857.777858.728
Non current assets subtotal-4,757.658-4,890.763
Current assets0000
Total Non current assets4,706.435-4,818.694-
Inventories318.833347.857340.35353.303
Trade and other receivables540.284417.472463.466487.438
Other current assets67.47671.59879.60386.321
Tax recoverable1.4073.6314.085.642
Derivative financial instruments00.190.1220.544
Assets held for sale--6.59827.614
Investment securities: Money market funds429.5387.957262.28207.1
Cash and bank balances254.949324.797298.394305.159
Current assets subtotal-1,553.502-1,488.617
Investment securities: Debt securities--015.496
Total assets6,319.2156,311.166,273.5876,379.38
EQUITY AND LIABILITIES0000
Total current assets1,612.78-1,454.893-
Current liabilities0000
Trade and other payables446.688417.058389.774380.65
Contract liabilities99.67196.08593.57194.47
Loans and borrowings33.7525.3529.363-
Lease liabilities23.8322.2219.908-
Income tax payable17.47510.52213.87316.427
Derivative financial instruments liabilities-0--
Loans and borrowings - current---190.069
Dividend payable-38.53--
Current liabilities subtotal-589.765-683.834
Lease liabilities - current---2.218
Net current assets1,013.127963.737926.112804.783
Total Current liabilities599.653-528.781-
Non current liabilities0000
Loan and borrowing: Senior Sukuk798.505798.482798.391-
Lease liabilities non current-24.489-20.402
Deferred tax liabilities130.261133.74141.483136.084
Loans and borrowings - non current---798.3
Provisions2.6132.6112.538.539
Non current liabilities subtotal-959.322-963.325
Total liabilities1,554.8641,549.0871,491.0931,647.159
Total Non current liabilities955.211-962.312-
Net assets4,764.3514,762.0734,782.4944,732.221
Equity attributable to owners of the parent0000
Share capital1,856.0981,856.0981,855.9411,855.937
Treasury shares-1,412.27-1,412.27-1,412.27-1,412.27
Retained earnings4,246.2964,207.1894,209.914,169.501
Other reserves51.19687.662102.05689.689
Total equity attributable to owners of the parent subtotal-4,738.679--
Non controlling interests23.03123.39426.85729.364
Total equity attributable to owners of the parent4,741.32-4,755.637-
Total equity4,764.3514,762.0734,782.4944,732.221
Equity subtotal---4,702.857
Perpetual Sukuk--00
Total equity and liabilities6,319.2156,311.166,273.5876,379.38

Cash Flow Statement

Metric
Q2 FY2026
RM '000
Q1 FY2026
RM '000
Q4 FY2025
RM '000
Q3 FY2025
RM '000
Operating activities0000
Profit before tax83.66845.198--
Depreciation and amortisation153.67476.673305.9228.659
Other adjustments5.447-1.62-32.222-24.081
Profit/(Loss) before tax--154.422106.591
Operating cash flows before changes in working capital242.789120.251428.1311.169
Changes in working capital0000
Net changes in current assets-66.85224.934-14.754-93.887
Net changes in current liabilities57.99823.832-63.995-67.431
Cash flows generated from operating activities233.935169.017349.351149.851
Interest paid-17.611-8.852-22.004-12.856
Income taxes paid-15.248-13.92-27.184-15.766
Net cash flows generated from operating activities201.076146.245300.163121.229
Investing activities0000
(Placement)/withdrawal of money market funds-162.032-122.954--
Purchase of property, plant and equipment-65.542-20.728-143.856-116.368
Proceeds from disposal of property, plant and equipment11.17311.029183.73139.104
Withdrawal of money market funds--368.681421.036
Proceeds from issuance of shares to non controlling interest0.0230.0231.30.959
Interest received18.59717.67711.6366.76
Disposal of debt securities--29.41114.107
Net cash flows (used in)/generated from investing activities-198.376-114.953--
Acquisition of equity interest of non-controlling interest-0.595---
Financing activities0000
Dividends paid on non controlling interests-2.25-2.25-0.567-0.567
Proceeds from issuance of ordinary shares0.1570.1576.6546.65
Payment of principal portion of lease liabilities-1.176-0.586-2.14-1.599
Net cash flows generated from investing activities--450.902465.598
Dividends paid on ordinary shares-38.527---
Repayment of loans and borrowings--1.857-402.499-235.233
Net cash flows used in financing activities-35.571-4.536-803.474-635.671
Net increase in cash and cash equivalents-26.756--
Effects of changes in foreign exchange rate-10.574-0.353-0.3842.816
Cash and cash equivalents at 1 September 2025/2024298.394298.394--
Net proceeds from issuance of Senior Sukuk0-798.191798.191
Distribution paid to Perpetual Sukuk holders0--23.113-23.113
Cash and cash equivalents at 30 November 2025/2024-324.797--
Redemption of Perpetual Sukuk0--1,180-1,180
Drawdown/(Repayment) of loans and borrowings6.225---
Net (decrease)/increase in cash and cash equivalents---52.409-48.844
Net decrease in cash and cash equivalents-32.871---
Cash and cash equivalents at 1 September 2024/2023--351.187351.187
Cash and cash equivalents at 31 August 2025/31 August 2024--298.394-
Cash and cash equivalents at 28 February 2026/2025254.949---
Cash and cash equivalents at 31 May 2025/2024---305.159
Investor Solutions

What's slowing down your research?

We're building customized tools for investors. Tell us your biggest challenge and we'll let you know when we solve it.

Source PDF